表紙
市場調査レポート

関節リウマチ - パイプライン分析

Rheumatoid Arthritis - Pipeline Review, H2 2015

発行 Global Markets Direct 商品コード 232779
出版日 ページ情報 英文 1175 Pages
即納可能
価格
本日の銀行送金レート: 1USD=106.12円で換算しております。
Back to Top
関節リウマチ - パイプライン分析 Rheumatoid Arthritis - Pipeline Review, H2 2015
出版日: 2015年12月30日 ページ情報: 英文 1175 Pages
概要

関節リウマチは慢性的自己免疫疾患で、最終的には奇形の原因となる骨の破壊につながります。体の免疫システムは自己と異物を識別することができず、異常な形で働くことがあります。関節はまず最初に影響を受け、こわばり、炎症に発展していきます。更に、この疾患は他の器官にも影響を及ぼします。 関節リウマチは遺伝的あるいは他の特殊な環境的要因によって引き起こされます。女性は特にかかりやすく、放置しておくと障害を含め、様々な合併症を引き起こします。

当レポートでは、関節リウマチの治療薬開発パイプラインの現況と最新アップデートによる各開発段階の比較分析、企業や研究機関によって開発中の治療薬、治療薬の評価、後期段階および中止されたプロジェクトに関する情報などを最新のニュースや発表も交えて提供しています。

イントロダクション

  • 関節リウマチ 概要

治療薬の開発

企業で開発中の治療薬

大学/機関で研究中の治療薬

パイプライン製品の概況

企業で開発中の製品

大学/機関で研究中の製品

治療薬開発に従事している企業

治療薬の評価

薬剤プロファイル

最近のパイプライン動向

休止中のプロジェクト

開発が中止された製品

製品開発のマイルストーン

付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GMDHC7298IDB

Summary

Global Markets Direct's, 'Rheumatoid Arthritis - Pipeline Review, H2 2015', provides an overview of the Rheumatoid Arthritis's therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Rheumatoid Arthritis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Rheumatoid Arthritis and special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global therapeutic landscape of Rheumatoid Arthritis
  • The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
  • The report reviews key players involved in the therapeutics development for Rheumatoid Arthritis and enlists all their major and minor projects
  • The report summarizes all the dormant and discontinued pipeline projects
  • A review of the Rheumatoid Arthritis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
  • Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • A detailed assessment of monotherapy and combination therapy pipeline projects
  • Coverage of the Rheumatoid Arthritis pipeline on the basis of target, MoA, route of administration and molecule type
  • Latest news and deals relating related to pipeline products

Reasons to buy

  • Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop strategic initiatives by understanding the focus areas of leading companies
  • Identify and understand important and diverse types of therapeutics under development for Rheumatoid Arthritis
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Devise corrective measures for pipeline projects by understanding Rheumatoid Arthritis pipeline depth and focus of Indication therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Table of Contents

  • Table of Contents
  • Introduction
  • Rheumatoid Arthritis Overview
  • Therapeutics Development
  • Rheumatoid Arthritis - Therapeutics under Development by Companies
  • Rheumatoid Arthritis - Therapeutics under Investigation by Universities/Institutes
  • Rheumatoid Arthritis - Pipeline Products Glance
  • Rheumatoid Arthritis - Products under Development by Companies
  • Rheumatoid Arthritis - Products under Investigation by Universities/Institutes
  • Rheumatoid Arthritis - Companies Involved in Therapeutics Development
  • Rheumatoid Arthritis - Therapeutics Assessment
  • Drug Profiles
  • Rheumatoid Arthritis - Recent Pipeline Updates
  • Rheumatoid Arthritis - Dormant Projects
  • Rheumatoid Arthritis - Dormant Projects
  • Rheumatoid Arthritis - Discontinued Products
  • Rheumatoid Arthritis - Product Development Milestones
  • Appendix

List of Tables

  • Number of Products under Development for Rheumatoid Arthritis, H2 2015
  • Number of Products under Development for Rheumatoid Arthritis - Comparative Analysis, H2 2015
  • Number of Products under Development by Companies, H2 2015
  • Number of Products under Development by Companies, H2 2015 (Contd..1)
  • Number of Products under Development by Companies, H2 2015 (Contd..2)
  • Number of Products under Development by Companies, H2 2015 (Contd..3)
  • Number of Products under Development by Companies, H2 2015 (Contd..4)
  • Number of Products under Development by Companies, H2 2015 (Contd..5)
  • Number of Products under Development by Companies, H2 2015 (Contd..6)
  • Number of Products under Development by Companies, H2 2015 (Contd..7)
  • Number of Products under Development by Companies, H2 2015 (Contd..8)
  • Number of Products under Development by Companies, H2 2015 (Contd..9)
  • Number of Products under Development by Companies, H2 2015 (Contd..10)
  • Number of Products under Development by Companies, H2 2015 (Contd..11)
  • Number of Products under Development by Companies, H2 2015 (Contd..12)
  • Number of Products under Development by Companies, H2 2015 (Contd..13)
  • Number of Products under Development by Companies, H2 2015 (Contd..14)
  • Number of Products under Development by Companies, H2 2015 (Contd..15)
  • Number of Products under Development by Companies, H2 2015 (Contd..16)
  • Number of Products under Development by Companies, H2 2015 (Contd..17)
  • Number of Products under Investigation by Universities/Institutes, H2 2015
  • Number of Products under Investigation by Universities/Institutes, H2 2015 (Contd..1)
  • Comparative Analysis by Late Stage Development, H2 2015
  • Comparative Analysis by Clinical Stage Development, H2 2015
  • Comparative Analysis by Early Stage Development, H2 2015
  • Comparative Analysis by Unknown Stage Development, H2 2015
  • Products under Development by Companies, H2 2015
  • Products under Development by Companies, H2 2015 (Contd..1)
  • Products under Development by Companies, H2 2015 (Contd..2)
  • Products under Development by Companies, H2 2015 (Contd..3)
  • Products under Development by Companies, H2 2015 (Contd..4)
  • Products under Development by Companies, H2 2015 (Contd..5)
  • Products under Development by Companies, H2 2015 (Contd..6)
  • Products under Development by Companies, H2 2015 (Contd..7)
  • Products under Development by Companies, H2 2015 (Contd..8)
  • Products under Development by Companies, H2 2015 (Contd..9)
  • Products under Development by Companies, H2 2015 (Contd..10)
  • Products under Development by Companies, H2 2015 (Contd..11)
  • Products under Development by Companies, H2 2015 (Contd..12)
  • Products under Development by Companies, H2 2015 (Contd..13)
  • Products under Development by Companies, H2 2015 (Contd..14)
  • Products under Development by Companies, H2 2015 (Contd..15)
  • Products under Development by Companies, H2 2015 (Contd..16)
  • Products under Development by Companies, H2 2015 (Contd..17)
  • Products under Development by Companies, H2 2015 (Contd..18)
  • Products under Development by Companies, H2 2015 (Contd..19)
  • Products under Development by Companies, H2 2015 (Contd..20)
  • Products under Development by Companies, H2 2015 (Contd..21)
  • Products under Development by Companies, H2 2015 (Contd..22)
  • Products under Development by Companies, H2 2015 (Contd..23)
  • Products under Development by Companies, H2 2015 (Contd..24)
  • Products under Development by Companies, H2 2015 (Contd..25)
  • Products under Development by Companies, H2 2015 (Contd..26)
  • Products under Development by Companies, H2 2015 (Contd..27)
  • Products under Investigation by Universities/Institutes, H2 2015
  • Products under Investigation by Universities/Institutes, H2 2015 (Contd..1)
  • Products under Investigation by Universities/Institutes, H2 2015 (Contd..2)
  • Rheumatoid Arthritis - Pipeline by 3SBio Inc., H2 2015
  • Rheumatoid Arthritis - Pipeline by 4D Pharma Plc, H2 2015
  • Rheumatoid Arthritis - Pipeline by 4SC AG, H2 2015
  • Rheumatoid Arthritis - Pipeline by AB Science SA, H2 2015
  • Rheumatoid Arthritis - Pipeline by AB2 Bio Ltd., H2 2015
  • Rheumatoid Arthritis - Pipeline by AbbVie Inc., H2 2015
  • Rheumatoid Arthritis - Pipeline by Ablynx NV, H2 2015
  • Rheumatoid Arthritis - Pipeline by ACEA Biosciences, Inc., H2 2015
  • Rheumatoid Arthritis - Pipeline by Addex Therapeutics Ltd, H2 2015
  • Rheumatoid Arthritis - Pipeline by Advinus Therapeutics Ltd., H2 2015
  • Rheumatoid Arthritis - Pipeline by Aegera Therapeutics Inc., H2 2015
  • Rheumatoid Arthritis - Pipeline by Alder Biopharmaceuticals Inc., H2 2015
  • Rheumatoid Arthritis - Pipeline by AlphaMab Co., Ltd, H2 2015
  • Rheumatoid Arthritis - Pipeline by Amgen Inc., H2 2015
  • Rheumatoid Arthritis - Pipeline by Amura Holdings Limited, H2 2015
  • Rheumatoid Arthritis - Pipeline by Aprogen, Inc., H2 2015
  • Rheumatoid Arthritis - Pipeline by Arena Pharmaceuticals, Inc., H2 2015
  • Rheumatoid Arthritis - Pipeline by arGentis Pharmaceuticals, LLC, H2 2015
  • Rheumatoid Arthritis - Pipeline by Arrien Pharmaceuticals, LLC, H2 2015
  • Rheumatoid Arthritis - Pipeline by Arthrogen BV, H2 2015
  • Rheumatoid Arthritis - Pipeline by Asahi Kasei Pharma Corp., H2 2015
  • Rheumatoid Arthritis - Pipeline by Aslan Pharmaceuticals Pte. Ltd., H2 2015
  • Rheumatoid Arthritis - Pipeline by Astellas Pharma Inc., H2 2015
  • Rheumatoid Arthritis - Pipeline by AstraZeneca Plc, H2 2015
  • Rheumatoid Arthritis - Pipeline by Avesthagen Limited, H2 2015
  • Rheumatoid Arthritis - Pipeline by Avexxin AS, H2 2015
  • Rheumatoid Arthritis - Pipeline by Axxam SpA, H2 2015
  • Rheumatoid Arthritis - Pipeline by Bio-Cancer Treatment International Limited, H2 2015
  • Rheumatoid Arthritis - Pipeline by BIOCAD, H2 2015
  • Rheumatoid Arthritis - Pipeline by Biocon Limited, H2 2015
  • Rheumatoid Arthritis - Pipeline by Biokine Therapeutics Ltd., H2 2015
  • Rheumatoid Arthritis - Pipeline by BioLingus AG, H2 2015
  • Rheumatoid Arthritis - Pipeline by Bionovis SA, H2 2015
  • Rheumatoid Arthritis - Pipeline by BioTherapeutics Inc., H2 2015
  • Rheumatoid Arthritis - Pipeline by Bird Rock Bio, Inc., H2 2015
  • Rheumatoid Arthritis - Pipeline by Boehringer Ingelheim GmbH, H2 2015
  • Rheumatoid Arthritis - Pipeline by Bone Medical Limited, H2 2015
  • Rheumatoid Arthritis - Pipeline by Boryung Pharmaceutical Co., Ltd., H2 2015
  • Rheumatoid Arthritis - Pipeline by Bristol-Myers Squibb Company, H2 2015
  • Rheumatoid Arthritis - Pipeline by Can-Fite BioPharma Ltd., H2 2015
  • Rheumatoid Arthritis - Pipeline by Cardax Pharmaceuticals, Inc., H2 2015
  • Rheumatoid Arthritis - Pipeline by CASI Pharmaceuticals Inc., H2 2015
  • Rheumatoid Arthritis - Pipeline by CEL-SCI Corporation, H2 2015
  • Rheumatoid Arthritis - Pipeline by Celgene Corporation, H2 2015
  • Rheumatoid Arthritis - Pipeline by Cellceutix Corporation, H2 2015
  • Rheumatoid Arthritis - Pipeline by Celltrion, Inc., H2 2015
  • Rheumatoid Arthritis - Pipeline by Cellworks Group, Inc., H2 2015
  • Rheumatoid Arthritis - Pipeline by ChemoCentryx, Inc., H2 2015
  • Rheumatoid Arthritis - Pipeline by Chipscreen Biosciences Ltd, H2 2015
  • Rheumatoid Arthritis - Pipeline by ChironWells GmbH, H2 2015
  • Rheumatoid Arthritis - Pipeline by Chong Kun Dang Pharmaceutical Corp., H2 2015
  • Rheumatoid Arthritis - Pipeline by CJ HealthCare Corp., H2 2015
  • Rheumatoid Arthritis - Pipeline by CLL Pharma, H2 2015
  • Rheumatoid Arthritis - Pipeline by Coherus BioSciences, Inc., H2 2015
  • Rheumatoid Arthritis - Pipeline by Commence Bio, Inc., H2 2015
  • Rheumatoid Arthritis - Pipeline by Compugen Ltd., H2 2015
  • Rheumatoid Arthritis - Pipeline by Confluence Life Sciences, Inc., H2 2015
  • Rheumatoid Arthritis - Pipeline by CrystalGenomics, Inc., H2 2015
  • Rheumatoid Arthritis - Pipeline by Cyclacel Pharmaceuticals, Inc., H2 2015
  • Rheumatoid Arthritis - Pipeline by Daiichi Sankyo Company, Limited, H2 2015
  • Rheumatoid Arthritis - Pipeline by Dong-A Socio Group, H2 2015
  • Rheumatoid Arthritis - Pipeline by Dr. Reddy's Laboratories Limited, H2 2015
  • Rheumatoid Arthritis - Pipeline by Effimune SAS, H2 2015
  • Rheumatoid Arthritis - Pipeline by Eisai Co., Ltd., H2 2015
  • Rheumatoid Arthritis - Pipeline by Eli Lilly and Company, H2 2015
  • Rheumatoid Arthritis - Pipeline by Emergent BioSolutions Inc., H2 2015
  • Rheumatoid Arthritis - Pipeline by Enceladus Pharmaceuticals BV, H2 2015
  • Rheumatoid Arthritis - Pipeline by Endocyte, Inc., H2 2015
  • Rheumatoid Arthritis - Pipeline by Ensemble Therapeutics Corporation, H2 2015
  • Rheumatoid Arthritis - Pipeline by Ensol Biosciences Inc., H2 2015
  • Rheumatoid Arthritis - Pipeline by Enzene Biosciences Ltd., H2 2015
  • Rheumatoid Arthritis - Pipeline by Epirus Biopharmaceuticals, Inc., H2 2015
  • Rheumatoid Arthritis - Pipeline by Exicure, Inc., H2 2015
  • Rheumatoid Arthritis - Pipeline by F. Hoffmann-La Roche Ltd., H2 2015
  • Rheumatoid Arthritis - Pipeline by Five Prime Therapeutics, Inc., H2 2015
  • Rheumatoid Arthritis - Pipeline by Fountain Biopharma Inc., H2 2015
  • Rheumatoid Arthritis - Pipeline by Galapagos NV, H2 2015
  • Rheumatoid Arthritis - Pipeline by Genentech, Inc., H2 2015
  • Rheumatoid Arthritis - Pipeline by Genor BioPharma Co., Ltd., H2 2015
  • Rheumatoid Arthritis - Pipeline by Genosco, H2 2015
  • Rheumatoid Arthritis - Pipeline by Gilead Sciences, Inc., H2 2015
  • Rheumatoid Arthritis - Pipeline by GlaxoSmithKline Plc, H2 2015
  • Rheumatoid Arthritis - Pipeline by Griffin Discoveries BV, H2 2015
  • Rheumatoid Arthritis - Pipeline by Handok Inc., H2 2015
  • Rheumatoid Arthritis - Pipeline by Hanmi Pharmaceuticals, Co. Ltd., H2 2015
  • Rheumatoid Arthritis - Pipeline by Hansa Medical AB, H2 2015
  • Rheumatoid Arthritis - Pipeline by Hanwha Chemical Corporation, H2 2015
  • Rheumatoid Arthritis - Pipeline by HEC Pharm Co., Ltd., H2 2015
  • Rheumatoid Arthritis - Pipeline by Hetero Drugs Limited, H2 2015
  • Rheumatoid Arthritis - Pipeline by Hospira, Inc., H2 2015
  • Rheumatoid Arthritis - Pipeline by Huabo Biopharm Co., Ltd., H2 2015
  • Rheumatoid Arthritis - Pipeline by Hutchison MediPharma Limited, H2 2015
  • Rheumatoid Arthritis - Pipeline by Idera Pharmaceuticals, Inc., H2 2015
  • Rheumatoid Arthritis - Pipeline by IMMD Inc., H2 2015
  • Rheumatoid Arthritis - Pipeline by Immune Response BioPharma, Inc., H2 2015
  • Rheumatoid Arthritis - Pipeline by ImmunoFrontier, Inc., H2 2015
  • Rheumatoid Arthritis - Pipeline by Inbiopro Solutions Pvt. Ltd., H2 2015
  • Rheumatoid Arthritis - Pipeline by Innate Pharma SA, H2 2015
  • Rheumatoid Arthritis - Pipeline by Innovent Biologics, Inc., H2 2015
  • Rheumatoid Arthritis - Pipeline by Intas Pharmaceuticals Ltd., H2 2015
  • Rheumatoid Arthritis - Pipeline by Invion Limited, H2 2015
  • Rheumatoid Arthritis - Pipeline by ISU ABXIS Co.,Ltd., H2 2015
  • Rheumatoid Arthritis - Pipeline by Jiangsu Hengrui Medicine Co., Ltd., H2 2015
  • Rheumatoid Arthritis - Pipeline by Johnson & Johnson, H2 2015
  • Rheumatoid Arthritis - Pipeline by Jyant Technologies, Inc., H2 2015
  • Rheumatoid Arthritis - Pipeline by Kadmon Corporation, LLC, H2 2015
  • Rheumatoid Arthritis - Pipeline by KAHR medical Ltd., H2 2015
  • Rheumatoid Arthritis - Pipeline by Karus Therapeutics Limited, H2 2015
  • Rheumatoid Arthritis - Pipeline by Kezar Life Sciences, Inc., H2 2015
  • Rheumatoid Arthritis - Pipeline by Kineta, Inc., H2 2015
  • Rheumatoid Arthritis - Pipeline by Lead Pharma Holding B.V., H2 2015
  • Rheumatoid Arthritis - Pipeline by LG Life Science LTD., H2 2015
  • Rheumatoid Arthritis - Pipeline by Lipocure Ltd., H2 2015
  • Rheumatoid Arthritis - Pipeline by Lupin Limited, H2 2015
  • Rheumatoid Arthritis - Pipeline by Mabion SA, H2 2015
  • Rheumatoid Arthritis - Pipeline by Mabtech Limited, H2 2015
  • Rheumatoid Arthritis - Pipeline by mAbxience S.A., H2 2015
  • Rheumatoid Arthritis - Pipeline by MacroGenics, Inc., H2 2015
  • Rheumatoid Arthritis - Pipeline by Mebiopharm Co., Ltd., H2 2015
  • Rheumatoid Arthritis - Pipeline by MedAnnex Ltd, H2 2015
  • Rheumatoid Arthritis - Pipeline by MediGene AG, H2 2015
  • Rheumatoid Arthritis - Pipeline by MedImmune, LLC, H2 2015
  • Rheumatoid Arthritis - Pipeline by Merck & Co., Inc., H2 2015
  • Rheumatoid Arthritis - Pipeline by Mertiva AB, H2 2015
  • Rheumatoid Arthritis - Pipeline by Mesoblast Limited, H2 2015
  • Rheumatoid Arthritis - Pipeline by MetrioPharm AG, H2 2015
  • Rheumatoid Arthritis - Pipeline by Mitsubishi Tanabe Pharma Corporation, H2 2015
  • Rheumatoid Arthritis - Pipeline by Modern Biosciences Plc, H2 2015
  • Rheumatoid Arthritis - Pipeline by ModiQuest B.V., H2 2015
  • Rheumatoid Arthritis - Pipeline by Momenta Pharmaceuticals, Inc., H2 2015
  • Rheumatoid Arthritis - Pipeline by Morphotek, Inc., H2 2015
  • Rheumatoid Arthritis - Pipeline by Mycenax Biotech Inc., H2 2015
  • Rheumatoid Arthritis - Pipeline by Myos Corporation, H2 2015
  • Rheumatoid Arthritis - Pipeline by Myungmoon pharmaceutical Co.,Ltd., H2 2015
  • Rheumatoid Arthritis - Pipeline by NanoSmart Pharmaceuticals, Inc., H2 2015
  • Rheumatoid Arthritis - Pipeline by Navigen Pharmaceuticals, Inc., H2 2015
  • Rheumatoid Arthritis - Pipeline by Neovacs SA, H2 2015
  • Rheumatoid Arthritis - Pipeline by Nichi-Iko Pharmaceutical Co., Ltd., H2 2015
  • Rheumatoid Arthritis - Pipeline by Nimbus Therapeutics, LLC, H2 2015
  • Rheumatoid Arthritis - Pipeline by Novartis AG, H2 2015
  • Rheumatoid Arthritis - Pipeline by NovImmune SA, H2 2015
  • Rheumatoid Arthritis - Pipeline by Nuevolution A/S, H2 2015
  • Rheumatoid Arthritis - Pipeline by Nuvo Research Inc., H2 2015
  • Rheumatoid Arthritis - Pipeline by Omeros Corporation, H2 2015
  • Rheumatoid Arthritis - Pipeline by Oncobiologics, Inc., H2 2015
  • Rheumatoid Arthritis - Pipeline by OncoImmune, Inc., H2 2015
  • Rheumatoid Arthritis - Pipeline by OPKO Health, Inc., H2 2015
  • Rheumatoid Arthritis - Pipeline by Opsona Therapeutics Limited, H2 2015
  • Rheumatoid Arthritis - Pipeline by Orchid Chemicals & Pharmaceuticals Ltd, H2 2015
  • Rheumatoid Arthritis - Pipeline by Oscotec Inc., H2 2015
  • Rheumatoid Arthritis - Pipeline by Padlock Therapeutics, Inc., H2 2015
  • Rheumatoid Arthritis - Pipeline by Panacea Biotec Limited, H2 2015
  • Rheumatoid Arthritis - Pipeline by Paras Biopharmaceuticals Finland Oy, H2 2015
  • Rheumatoid Arthritis - Pipeline by Peptinnovate Limited, H2 2015
  • Rheumatoid Arthritis - Pipeline by Peptinov SAS, H2 2015
  • Rheumatoid Arthritis - Pipeline by Pfenex Inc., H2 2015
  • Rheumatoid Arthritis - Pipeline by Pfizer Inc., H2 2015
  • Rheumatoid Arthritis - Pipeline by Pharmacyclics, Inc., H2 2015
  • Rheumatoid Arthritis - Pipeline by PharmaIN Corporation, H2 2015
  • Rheumatoid Arthritis - Pipeline by Pharmedartis GmbH, H2 2015
  • Rheumatoid Arthritis - Pipeline by Phenex Pharmaceuticals AG, H2 2015
  • Rheumatoid Arthritis - Pipeline by Philogen S.p.A., H2 2015
  • Rheumatoid Arthritis - Pipeline by Principia Biopharma Inc., H2 2015
  • Rheumatoid Arthritis - Pipeline by Progenra, Inc., H2 2015
  • Rheumatoid Arthritis - Pipeline by ProNoxis AB, H2 2015
  • Rheumatoid Arthritis - Pipeline by ProtAb Ltd, H2 2015
  • Rheumatoid Arthritis - Pipeline by Protagonist Therapeutics Inc., H2 2015
  • Rheumatoid Arthritis - Pipeline by Protalex, Inc., H2 2015
  • Rheumatoid Arthritis - Pipeline by Protalix BioTherapeutics, Inc., H2 2015
  • Rheumatoid Arthritis - Pipeline by Provid Pharmaceuticals, Inc., H2 2015
  • Rheumatoid Arthritis - Pipeline by Qu Biologics Inc., H2 2015
  • Rheumatoid Arthritis - Pipeline by R-Pharm, H2 2015
  • Rheumatoid Arthritis - Pipeline by Re-Pharm Limited, H2 2015
  • Rheumatoid Arthritis - Pipeline by ReceptoPharm, Inc., H2 2015
  • Rheumatoid Arthritis - Pipeline by RedHill Biopharma Ltd., H2 2015
  • Rheumatoid Arthritis - Pipeline by Redx Pharma Plc, H2 2015
  • Rheumatoid Arthritis - Pipeline by Regeneron Pharmaceuticals, Inc., H2 2015
  • Rheumatoid Arthritis - Pipeline by Resverlogix Corp., H2 2015
  • Rheumatoid Arthritis - Pipeline by ReveraGen BioPharma, Inc., H2 2015
  • Rheumatoid Arthritis - Pipeline by Rhizen Pharmaceuticals S.A., H2 2015
  • Rheumatoid Arthritis - Pipeline by Richter Gedeon Nyrt., H2 2015
  • Rheumatoid Arthritis - Pipeline by Rottapharm SpA, H2 2015
  • Rheumatoid Arthritis - Pipeline by Salix Pharmaceuticals Ltd., H2 2015
  • Rheumatoid Arthritis - Pipeline by Sandoz International GmbH, H2 2015
  • Rheumatoid Arthritis - Pipeline by Sareum Holdings Plc, H2 2015
  • Rheumatoid Arthritis - Pipeline by SBI Biotech Co., Ltd., H2 2015
  • Rheumatoid Arthritis - Pipeline by Selvita SA, H2 2015
  • Rheumatoid Arthritis - Pipeline by Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd., H2 2015
  • Rheumatoid Arthritis - Pipeline by Shanghai Henlius Biotech Co., Ltd., H2 2015
  • Rheumatoid Arthritis - Pipeline by Shanghai Pharmaceutical Co., Ltd., H2 2015
  • Rheumatoid Arthritis - Pipeline by Swedish Orphan Biovitrum AB, H2 2015
  • Rheumatoid Arthritis - Pipeline by Synovo GmbH, H2 2015
  • Rheumatoid Arthritis - Pipeline by Syntrix Biosystems, Inc., H2 2015
  • Rheumatoid Arthritis - Pipeline by TaiwanJ Pharmaceuticals Co., Ltd., H2 2015
  • Rheumatoid Arthritis - Pipeline by Takeda Pharmaceutical Company Limited, H2 2015
  • Rheumatoid Arthritis - Pipeline by TechnoPhage SA, H2 2015
  • Rheumatoid Arthritis - Pipeline by Teijin Pharma Limited, H2 2015
  • Rheumatoid Arthritis - Pipeline by The International Biotechnology Center (IBC) Generium, H2 2015
  • Rheumatoid Arthritis - Pipeline by TheraMAB LLC, H2 2015
  • Rheumatoid Arthritis - Pipeline by Therapeutic Proteins International, LLC, H2 2015
  • Rheumatoid Arthritis - Pipeline by TiGenix NV, H2 2015
  • Rheumatoid Arthritis - Pipeline by Toleranzia AB, H2 2015
  • Rheumatoid Arthritis - Pipeline by Tumorend, LLC, H2 2015
  • Rheumatoid Arthritis - Pipeline by TxCell SA, H2 2015
  • Rheumatoid Arthritis - Pipeline by U.S. Stem Cell, Inc., H2 2015
  • Rheumatoid Arthritis - Pipeline by UCB S.A., H2 2015
  • Rheumatoid Arthritis - Pipeline by ugichem GmbH, H2 2015
  • Rheumatoid Arthritis - Pipeline by Unizyme Laboratories A/S, H2 2015
  • Rheumatoid Arthritis - Pipeline by Vaccinex, Inc., H2 2015
  • Rheumatoid Arthritis - Pipeline by Vichem Chemie Research Ltd., H2 2015
  • Rheumatoid Arthritis - Pipeline by Vicore Pharma AB, H2 2015
  • Rheumatoid Arthritis - Pipeline by Vida Therapeutics Inc., H2 2015
  • Rheumatoid Arthritis - Pipeline by Vitae Pharmaceuticals, Inc., H2 2015
  • Rheumatoid Arthritis - Pipeline by Vivia Biotech, S.L., H2 2015
  • Rheumatoid Arthritis - Pipeline by Xbrane Bioscience AB, H2 2015
  • Rheumatoid Arthritis - Pipeline by Xencor, Inc., H2 2015
  • Rheumatoid Arthritis - Pipeline by XTL Biopharmaceuticals Ltd., H2 2015
  • Rheumatoid Arthritis - Pipeline by Yuhan Corporation, H2 2015
  • Rheumatoid Arthritis - Pipeline by Yungjin Pharm. Co., Ltd., H2 2015
  • Rheumatoid Arthritis - Pipeline by Yuyu Pharma, Inc., H2 2015
  • Rheumatoid Arthritis - Pipeline by Zenyaku Kogyo Co., Ltd., H2 2015
  • Rheumatoid Arthritis - Pipeline by Zydus Cadila Healthcare Limited, H2 2015
  • Assessment by Monotherapy Products, H2 2015
  • Assessment by Combination Products, H2 2015
  • Number of Products by Stage and Target, H2 2015
  • Number of Products by Stage and Mechanism of Action, H2 2015
  • Number of Products by Stage and Route of Administration, H2 2015
  • Number of Products by Stage and Molecule Type, H2 2015
  • Rheumatoid Arthritis Therapeutics - Recent Pipeline Updates, H2 2015
  • Rheumatoid Arthritis - Dormant Projects, H2 2015
  • Rheumatoid Arthritis - Dormant Projects (Contd..1), H2 2015
  • Rheumatoid Arthritis - Dormant Projects (Contd..2), H2 2015
  • Rheumatoid Arthritis - Dormant Projects (Contd..3), H2 2015
  • Rheumatoid Arthritis - Dormant Projects (Contd..4), H2 2015
  • Rheumatoid Arthritis - Dormant Projects (Contd..5), H2 2015
  • Rheumatoid Arthritis - Dormant Projects (Contd..6), H2 2015
  • Rheumatoid Arthritis - Dormant Projects (Contd..7), H2 2015
  • Rheumatoid Arthritis - Dormant Projects (Contd..8), H2 2015
  • Rheumatoid Arthritis - Dormant Projects (Contd..9), H2 2015
  • Rheumatoid Arthritis - Dormant Projects (Contd..10), H2 2015
  • Rheumatoid Arthritis - Dormant Projects (Contd..11), H2 2015
  • Rheumatoid Arthritis - Dormant Projects (Contd..12), H2 2015
  • Rheumatoid Arthritis - Dormant Projects (Contd..13), H2 2015
  • Rheumatoid Arthritis - Dormant Projects (Contd..14), H2 2015
  • Rheumatoid Arthritis - Dormant Projects (Contd..15), H2 2015
  • Rheumatoid Arthritis - Dormant Projects (Contd..16), H2 2015
  • Rheumatoid Arthritis - Dormant Projects (Contd..17), H2 2015
  • Rheumatoid Arthritis - Dormant Projects (Contd..18), H2 2015
  • Rheumatoid Arthritis - Dormant Projects (Contd..19), H2 2015
  • Rheumatoid Arthritis - Dormant Projects (Contd..20), H2 2015
  • Rheumatoid Arthritis - Dormant Projects (Contd..21), H2 2015
  • Rheumatoid Arthritis - Dormant Projects (Contd..22), H2 2015
  • Rheumatoid Arthritis - Dormant Projects (Contd..23), H2 2015
  • Rheumatoid Arthritis - Dormant Projects (Contd..24), H2 2015
  • Rheumatoid Arthritis - Dormant Projects (Contd..25), H2 2015
  • Rheumatoid Arthritis - Dormant Projects (Contd..26), H2 2015
  • Rheumatoid Arthritis - Dormant Projects (Contd..27), H2 2015
  • Rheumatoid Arthritis - Dormant Projects (Contd..28), H2 2015
  • Rheumatoid Arthritis - Dormant Projects (Contd..29), H2 2015
  • Rheumatoid Arthritis - Dormant Projects (Contd..30), H2 2015
  • Rheumatoid Arthritis - Dormant Projects (Contd..31), H2 2015
  • Rheumatoid Arthritis - Dormant Projects (Contd..32), H2 2015
  • Rheumatoid Arthritis - Dormant Projects (Contd..33), H2 2015
  • Rheumatoid Arthritis - Dormant Projects (Contd..34), H2 2015
  • Rheumatoid Arthritis - Dormant Projects (Contd..35), H2 2015
  • Rheumatoid Arthritis - Dormant Projects (Contd..36), H2 2015
  • Rheumatoid Arthritis - Dormant Projects (Contd..37), H2 2015
  • Rheumatoid Arthritis - Dormant Projects (Contd..38), H2 2015
  • Rheumatoid Arthritis - Dormant Projects (Contd..39), H2 2015
  • Rheumatoid Arthritis - Dormant Projects (Contd..40), H2 2015
  • Rheumatoid Arthritis - Dormant Projects (Contd..41), H2 2015
  • Rheumatoid Arthritis - Dormant Projects (Contd..42), H2 2015
  • Rheumatoid Arthritis - Discontinued Products, H2 2015
  • Rheumatoid Arthritis - Discontinued Products (Contd..1), H2 2015
  • Rheumatoid Arthritis - Discontinued Products (Contd..2), H2 2015
  • Rheumatoid Arthritis - Discontinued Products (Contd..3), H2 2015
  • Rheumatoid Arthritis - Discontinued Products (Contd..4), H2 2015
  • Rheumatoid Arthritis - Discontinued Products (Contd..5), H2 2015
  • Rheumatoid Arthritis - Discontinued Products (Contd..6), H2 2015
  • Rheumatoid Arthritis - Discontinued Products (Contd..7), H2 2015
  • Rheumatoid Arthritis - Discontinued Products (Contd..8), H2 2015
  • Rheumatoid Arthritis - Discontinued Products (Contd..9), H2 2015
  • Rheumatoid Arthritis - Discontinued Products (Contd..10), H2 2015
  • Rheumatoid Arthritis - Discontinued Products (Contd..11), H2 2015

List of Figures

  • Number of Products under Development for Rheumatoid Arthritis, H2 2015
  • Number of Products under Development for Rheumatoid Arthritis - Comparative Analysis, H2 2015
  • Number of Products under Development by Companies, H2 2015
  • Number of Products under Investigation by Universities/Institutes, H2 2015
  • Comparative Analysis by Late Stage Development, H2 2015
  • Comparative Analysis by Clinical Stage Development, H2 2015
  • Comparative Analysis by Early Stage Products, H2 2015
  • Assessment by Monotherapy Products, H2 2015
  • Number of Products by Top 10 Targets, H2 2015
  • Number of Products by Stage and Top 10 Targets, H2 2015
  • Number of Products by Top 10 Mechanism of Actions, H2 2015
  • Number of Products by Stage and Top 10 Mechanism of Actions, H2 2015
  • Number of Products by Top 10 Routes of Administration, H2 2015
  • Number of Products by Stage and Top 10 Routes of Administration, H2 2015
  • Number of Products by Top 10 Molecule Types, H2 2015
  • Number of Products by Stage and Top 10 Molecule Types, H2 2015
Back to Top